No Data
The "Liberation Day" of Trump's tariffs is approaching, and the pharmaceutical Industry may not be among the targets.
According to reports, President Trump of the USA is expected to announce a series of broader tariff measures on local time April 2 (Wednesday), which will not include any specific details on Pharmaceutical tariffs.
Wolfe Research Maintains Blueprint Medicines(BPMC.US) With Buy Rating, Maintains Target Price $132
Blueprint Medicines to Present at 24th Annual Needham Virtual Healthcare Conference
Blueprint Medicines Corporation's (NASDAQ:BPMC) Shift From Loss To Profit
THE PROLIFT RIGGING COMPANY LAUNCHES STRATEGIC PARTNERSHIP WITH BLUEPRINT SUPPLY CHAIN TO AID DATA CENTER CONSTRUCTION
Is Blueprint Medicines Corporation (BPMC) a Promising Biotech Stock According to Wall Street Analysts